Objectives/HypothesisThe objectives of this study were to describe singing voice therapy (SVT), describe referred patient characteristics, and document the outcomes of SVT.Study DesignRetrospective.MethodsRecords of patients receiving SVT between June 2008 and June 2013 were reviewed (n = 51). All diagnoses were included. Demographic information, number of SVT sessions, and symptom severity were retrieved from the medical record. Symptom severity was measured via the 10‐item Singing Voice Handicap Index (SVHI‐10). Treatment outcome was analyzed by diagnosis, history of previous training, and SVHI‐10.ResultsSVHI‐10 scores decreased following SVT (mean change = 11, 40% decrease) (P < .001). Approximately 18% (n = 9) of patient SVHI‐10 scores decreased to normal range. The average number of sessions attended was three (± 2); patients who concurrently attended singing lessons (n = 10) also completed an average of three SVT sessions. Primary muscle tension dysphonia (MTD1) and benign vocal fold lesion (lesion) were the most common diagnoses. Most patients (60%) had previous vocal training. SVHI‐10 decrease was not significantly different between MTD and lesion.ConclusionsThis is the first outcome‐based study of SVT in a disordered population. Diagnosis of MTD or lesion did not influence treatment outcomes. Duration of SVT was short (approximately three sessions). Voice care providers are encouraged to partner with a singing voice therapist to provide optimal care for the singing voice. This study supports the use of SVT as a tool for the treatment of singing voice disorders.Level of Evidence4 Laryngoscope, 126:2546–2551, 2016